The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
The biology of depression in cancer and the relationship between depression and cancer progression
Abstract
The prevalence of depressive symptoms in patients with cancer exceeds that observed in the general population and depression is associated with a poorer prognosis in cancer patients. The increased prevalence is not solely explained by the psychosocial stress associated with the diagnosis. Pro-inflammatory cytokines, which induce sickness behaviour with symptoms overlapping those of clinical depression, are validated biomarkers of increased inflammation in patients with cancer. A growing literature reveals that chronic inflammatory processes associated with stress may also underlie depression symptoms in general, and in patients with cancer in particular. Therapeutic modalities, which are frequently poorly tolerated, are used in the treatment of cancer. These interventions are associated with inflammatory reactions, which may help to explain their toxicity. There is evidence that antidepressants can effectively treat symptoms of depression in cancer patients though the database is meager. Novel agents with anti-inflammatory properties may be effective alternatives for patients with treatment-resistant depression who exhibit evidence of increased inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399 · cited 1×
“Infl ammation has been linked to 15 – 20% of all deaths from cancer worldwide (Mantovani et al., 2008).”
BackgroundFrom inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · cited 1×
“Meta analyses have revealed that elevated peripheral blood levels of IL-6, TNF- α , and CRP are the most reliable fi ndings in patients with depression (Dowlati et al., 2010; Zorrilla et al., 2001).”
BackgroundInflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
EFFECT OF PSYCHOSOCIAL TREATMENT ON SURVIVAL OF PATIENTS WITH METASTATIC BREAST CANCER
Spiegel, D., Kraemer, H., Bloom, J., & Gottheil, E. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91551-1 · Cited by 2,353
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617 · cited 1×
“Infl iximab reduced depressive symptoms in patients with increased baseline infl ammation as defi ned by CRP concentrations 5 mg/L (Raison et al., 2013).”
BackgroundImmunoregulatory Feedback Between Interleukin-1 and Glucocorticoid Hormones
Besedovsky, H., del Rey, A., Sorkin, E., & Dinarello, C. A. (1986) · Science · doi:10.1126/science.3014662 · Cited by 1,519 · cited 1×
“Second, they stimulate the hypothalamic – pituitary – adrenal (HPA) axis through increased release of corticotropin releasing hormone (CRH) (Besedovsky et al., 1986; Rivier, 1995).”
BackgroundPrevalence of depression in patients with cancer
Massie, M. J. (2004) · Journal of the National Cancer Institute Monographs · doi:10.1093/jncimonographs/lgh014 · Cited by 1,408
Adverse childhood experiences and the risk of premature mortality
Brown, D. W., Anda, R. F., Tiemeier, H., Felitti, V. J., Edwards, V. J., Croft, J. B., & Giles, W. H. (2009) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2009.06.021 · Cited by 1,369
Tracey, K. J. (2009) · Nature Reviews Immunology · doi:10.1038/nri2566 · Cited by 1,154 · cited 10×
“Meta analyses have revealed that elevated peripheral blood levels of IL-6, TNF- α , and CRP are the most reliable fi ndings in patients with depression (Dowlati et al., 2010; Zorrilla et al., 2001).”
BackgroundInfluentialGlucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147 · cited 1×
“Third, pro-infl ammatory cytokines may induce resistance of nervous, endocrine, and immune system tissues to circulating glucocorticoid hormones through direct effects on the expression or function of glucocorticoid receptors (Pariante & Miller, 2001).”
BackgroundParoxetine for the prevention of depression induced by high-dose interferon alfa.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441303 · Cited by 1,120 · cited 5×
“As previously noted, paroxetine prior to cancer treatment has been found to be effective in reducing depressive symptoms in cancer patients undergoing chemotherapy with IFN- α (Musselman et al., 2001a).”
BackgroundResultInfluentialSelf-citationDiurnal Cortisol Rhythm as a Predictor of Breast Cancer Survival
Sephton, S. E. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.12.994 · Cited by 1,082
Tyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(05)67763-x · Cited by 1,069 · cited 2×
“For example, the rs12150214 SNP of the SLC6A4 serotonin transporter gene has been associated with Beck Depression Inventory severity depression scores and elevated IL-6 levels in some populations (Su et al., 2009).”
MethodThe Relationship of Depression and Stressors to Immunological Assays: A Meta-Analytic Review
Zorrilla, E. P., Luborsky, L., McKay, J. R., Rosenthal, R., Houldin, A., Tax, A., McCorkle, R., Seligman, D. A., & Schmidt, K. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2000.0597 · Cited by 995 · cited 1×
“Meta analyses have revealed that elevated peripheral blood levels of IL-6, TNF- α , and CRP are the most reliable fi ndings in patients with depression (Dowlati et al., 2010; Zorrilla et al., 2001).”
BackgroundDepression as a predictor of disease progression and mortality in cancer patients: A Meta‐Analysis
Satin, J. R., Linden, W., & Phillips, M. J. (2009) · Cancer · doi:10.1002/cncr.24561 · Cited by 972 · cited 1×
“…cancer patients, depression has been associated with increased mortality (Falagas et al., 2007; Giese-Davis et al., 2011) and clinical trials of interventions that treat depression have reported increased survival in women with metastatic disease (Giese-Davis et al., 2011; Satin et al., 2009).”
BackgroundA mechanism converting psychosocial stress into mononuclear cell activation
Bierhaus, A., Wolf, J., Andrassy, M., Rohleder, N., Humpert, P. M., Petrov, D., Ferstl, R., von Eynatten, M., Wendt, T., Rudofsky, G., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438019100 · Cited by 927
Pace, T. W. W., Mletzko, T. C., Alagbe, O., Musselman, D. L., Nemeroff, C. B., Miller, A. H., & Heim, C. M. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1630 · Cited by 810
Self-citationCapuron, L. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00407-9 · Cited by 797 · cited 4×
“Two types of sickness behaviour have been identifi ed in humans: a depressive type, which responds to treatment with antidepressants, and a neurovegetative type, which does not (Capuron et al., 2002a).”
BackgroundInfluentialMüller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Müller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001805 · Cited by 794
Loprinzi, C. L., Kugler, J. W., Sloan, J. A., Mailliard, J. A., LaVasseur, B. I., Barton, D. L., Novotny, P. J., Dakhil, S. R., Rodger, K., Rummans, T. A., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03403-6 · Cited by 737
Cytokine Production and Treatment Response in Major Depressive Disorder
Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735
Elevated inflammation levels in depressed adults with a history of childhood maltreatment
Danese, A., Moffitt, T. E., Pariante, C. M., Ambler, A., Poulton, R., & Caspi, A. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.4.409 · Cited by 641 · cited 1×
“…to the age of 32, those with current major depression and a history of childhood maltreatment were over twice as likely to exhibit elevated peripheral blood concentrations of high sensitivity CRP ( 3 mg/L) compared with equally depressed individuals without a history of abuse (Danese et al., 2008).”
BackgroundRaison, C. L., Dantzer, R., Kelley, K. W., Lawson, M. A., Woolwine, B. J., Vogt, G., Spivey, J. R., Saito, K., & Miller, A. H. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.116 · Cited by 630 · cited 1×
“…C virus treated with interferon α (IFN- α ), increases in cerebrospinal fl uid (CSF) kynurenine and quinolinic acid were correlated with increased CSF IFN- α , soluble TNF- α receptor 2, and monocyte chemoattractant protein-1, as well as increased symptoms of depression (Raison et al., 2010).”
Inflammation-Induced Anhedonia: Endotoxin Reduces Ventral Striatum Responses to Reward
Eisenberger, N. I., Berkman, E. T., Inagaki, T. K., Rameson, L. T., Mashal, N. M., & Irwin, M. R. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.010 · Cited by 596
Major depression after breast cancer: a review of epidemiology and treatment
Fann, J. R., Thomas-Rich, A. M., Katon, W. J., Cowley, D., Pepping, M., McGregor, B. A., & Gralow, J. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.10.008 · Cited by 586
Depression and immune function
Kiecolt-Glaser, J. K., & Glaser, R. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00309-4 · Cited by 571 · cited 1×
“Several studies suggest that pro-infl ammatory cytokines may be involved in depression in both medically healthy and medically ill individuals, including patients with cancer (Dantzer et al., 2008; Capuron & Dantzer, 2003; Kiecolt-Glaser & Glaser, 2002; Raison & Miller, 2003).”
BackgroundA meta-analytic review of polyunsaturated fatty acid compositions in patients with depression
Lin, P.-Y., Huang, S.-Y., & Su, K.-P. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.03.018 · Cited by 530
Lindqvist, D., Janelidze, S., Hagell, P., Erhardt, S., Samuelsson, M., Minthon, L., Hansson, O., Björkqvist, M., Träskman-Bendz, L., & Brundin, L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.030 · Cited by 524 · cited 1×
“They also reduce the activity of mesolimbic and mesocortical dopamine systems, as evidenced by reduced CSF concentrations of homovanillic acid (HVA), the major dopamine metabolite (Lindqvist et al., 2009).”
BackgroundWatkins, L. R., Goehler, L. E., Relton, J. K., Tartaglia, N., Silbert, L., Martin, D., & Maier, S. F. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(94)11105-r · Cited by 516
Interferon-alpha–induced changes in tryptophan metabolism
Capuron, L., Neurauter, G., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., Fuchs, D., & Miller, A. H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00173-2 · Cited by 493
Self-citationNeuropsychiatric Adverse Effects of Interferon-??: Recognition and Management
Raison, C. L., Demetrashvili, M., Capuron, L., & Miller, A. H. (2005) · CNS Drugs · doi:10.2165/00023210-200519020-00002 · Cited by 483
Capuron, L., Ravaud, A., Neveu, P. J., Miller, A. H., Maes, M., & Dantzer, R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000995 · Cited by 473 · cited 4×
“Two types of sickness behaviour have been identifi ed in humans: a depressive type, which responds to treatment with antidepressants, and a neurovegetative type, which does not (Capuron et al., 2002a).”
BackgroundInfluentialPhase III Evaluation of Fluoxetine for Treatment of Hot Flashes
Loprinzi, C. L., Sloan, J. A., Perez, E. A., Quella, S. K., Stella, P. J., Mailliard, J. A., Halyard, M. Y., Pruthi, S., Novotny, P. J., & Rummans, T. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.6.1578 · Cited by 473 · cited 1×
“…to treating depression symptoms, antidepressants may also be effective in treating other symptoms commonly found in patients with cancer, such as hot fl ushes (Loprinzi et al., 2000, 2002; Stearns et al., 2000) and neuropathic pain (Max et al., 1992; Semenchuk et al., 2001; Sumpton & Moulin, 2001).”
BackgroundSleep Loss Activates Cellular Inflammatory Signaling
Irwin, M. R., Wang, M., Ribeiro, D., Cho, H. J., Olmstead, R., Breen, E. C., Martinez-Maza, O., & Cole, S. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.004 · Cited by 467
Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults
Carpenter, L. L., Gawuga, C. E., Tyrka, A. R., Lee, J. K., Anderson, G. M., & Price, L. H. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.159 · Cited by 464
Giese-Davis, J., Collie, K., Rancourt, K. M. S., Neri, E., Kraemer, H. C., & Spiegel, D. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.4455 · Cited by 458
Activity in human ventral striatum locked to errors of reward prediction
Pagnoni, G., Zink, C. F., Montague, P. R., & Berns, G. S. (2002) · Nature Neuroscience · doi:10.1038/nn802 · Cited by 451 · cited 2×
“Functional MRI and PET neuroimaging studies in patients treated with IFN- α have revealed reduced basal ganglia activity compared with control subjects (Juengling et al., 2000; Pagnoni et al., 2002).”
BackgroundCatecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines
Johnson, J. D., Campisi, J., Sharkey, C. M., Kennedy, S. L., Nickerson, M., Greenwood, B. N., & Fleshner, M. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.090 · Cited by 424
Pelletier, G., Verhoef, M. J., Khatri, N., & Hagen, N. (2002) · Journal of Neuro-Oncology · doi:10.1023/a:1015728825642 · Cited by 362 · cited 1×
“…medical outcomes in these patients by resulting in an increase in length of hospitalizations, diminishing quality of life, a reduction in the ability to care for oneself, and a decrease in compliance with treatments (Koenig et al., 1989, 1992; Pelletier et al., 2002; Stoudemire & Thompson, 1983).”
BackgroundEffects of Cytokines on Cerebral Neurotransmission: Comparison with the Effects of Stress
Dunn, A. J., Wang, J., & Ando, T. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_8 · Cited by 316
Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer
Bower, J. E., Ganz, P. A., Tao, M. L., Hu, W., Belin, T. R., Sepah, S., Cole, S., & Aziz, N. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2584 · Cited by 315
An fMRI study of cytokine-induced depressed mood and social pain: The role of sex differences
Eisenberger, N. I., Inagaki, T. K., Rameson, L. T., Mashal, N. M., & Irwin, M. R. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.04.040 · Cited by 313
Capuron, L., Raison, C. L., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., & Miller, A. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1342 · Cited by 308 · cited 1×
“Those patients who develop depression after interferon- α exhibit increased ACTH and cortisol responses to the initial dose of this agent (Capuron et al., 2003a).”
BackgroundSelf-citationWarner-Schmidt, J. L., Vanover, K. E., Chen, E. Y., Marshall, J. J., & Greengard, P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104836108 · Cited by 291
Mendlewicz, J., Kriwin, P., Oswald, P., Souery, D., Alboni, S., & Brunello, N. (2006) · International Clinical Psychopharmacology · doi:10.1097/00004850-200607000-00005 · Cited by 229
Depression and Survival in Metastatic Non–Small-Cell Lung Cancer: Effects of Early Palliative Care
Pirl, W. F., Greer, J. A., Traeger, L., Jackson, V., Lennes, I. T., Gallagher, E. R., Perez-Cruz, P., Heist, R. S., & Temel, J. S. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.3166 · Cited by 228 · cited 1×
“In other studies, the depressive coping style of patients with lung cancer correlated with decreased survival (Faller, 1999), and major depression was associated with worse survival in patients with non-small cell lung carcinoma (Pirl et al., 2012).”
ResultBull, S. J., Huezo-Diaz, P., Binder, E. B., Cubells, J. F., Ranjith, G., Maddock, C., Miyazaki, C., Alexander, N., Hotopf, M., Cleare, A. J., et al. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.48 · Cited by 228
Bufalino, C., Hepgul, N., Aguglia, E., & Pariante, C. M. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.04.009 · Cited by 228
Stearns, V., Isaacs, C., Rowland, J., Crawford, J., Ellis, M. J., Kramer, R., Lawrence, W., Hanfelt, J. J., & Hayes, D. F. (2000) · Annals of Oncology · doi:10.1023/a:1008382706068 · Cited by 224
Cytokines, “depression due to a general medical condition”, and antidepressant drugs
Yirmiya, R., Weidenfeld, J., Pollak, Y., Morag, M., Morag, A., Avitsur, R., Barak, O., Reichenberg, A., Cohen, E., Shavit, Y., et al. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_16 · Cited by 208 · cited 2×
“…ammatory cytokines such as tumour necrosis factor α (TNF- α ), interleukin 1 (IL-1), and interleukin 6 (IL-6) are capable of inducing the previously described ‘ sickness behaviour syndrome ’ (Yirmiya et al., 1999) with its symptom profi le overlapping substantially with that of major depression.”
BackgroundEfficacy and safety of mianserin in the treatment of depression of women with cancer
Costa, D., Mogos, I., & Toma, T. (1985) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1985.tb08081.x · Cited by 202 · cited 1×
“Several randomized controlled trials have been conducted since then with other antidepressants, including mianserin (Costa et al., 1985; van Heeringen & Zivkov, 1996), fl uoxetine (Razavi et al., 1996), desipramine (Holland et al., 1998), amitriptyline and paroxetine (Musselman et al., 2001a;…”
ResultSurvival and Health Care Utilization in Elderly Medical Inpatients With Major Depression
Koenig, H. G., Shelp, F., Goli, V., Cohen, H. J., & Blazer, D. G. (1989) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1989.tb01249.x · Cited by 192 · cited 1×
“…medical outcomes in these patients by resulting in an increase in length of hospitalizations, diminishing quality of life, a reduction in the ability to care for oneself, and a decrease in compliance with treatments (Koenig et al., 1989, 1992; Pelletier et al., 2002; Stoudemire & Thompson, 1983).”
BackgroundMonk, J. P., Phillips, G., Waite, R., Kuhn, J., Schaaf, L. J., Otterson, G. A., Guttridge, D., Rhoades, C., Shah, M., Criswell, T., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2838 · Cited by 179 · cited 3×
“In addition, recent studies also suggest that blocking the effect of infl ammatory cytokines reduces symptoms of depression, especially physical fatigue, in cancer patients (Monk et al., 2006).”
BackgroundLestage, J., Verrier, D., Palin, K., & Dantzer, R. (2002) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(02)00014-4 · Cited by 170 · cited 1×
“…serotonin availability indirectly through their effects on appetite and decreased dietary intake and directly through the induction of indolamine 2,3 dioxygenase (IDO), the enzyme that breaks down tryptophan into kynurenine (Capuron et al., 2002b; Lestage et al., 2002; Liebau et al., 2002).”
BackgroundCapuron, L., Fornwalt, F. B., Knight, B. T., Harvey, P. D., Ninan, P. T., & Miller, A. H. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.02.017 · Cited by 164
Prefrontal cortical hypometabolism during low-dose interferon alpha treatment
Juengling, F. D., Ebert, D., Gut, O., Engelbrecht, M. A., Rasenack, J., Nitzsche, E. U., Bauer, J., & Lieb, K. (2000) · Psychopharmacology · doi:10.1007/s002130000549 · Cited by 149
RAISON, C. L., WOOLWINE, B. J., DEMETRASHVILI, M. F., BORISOV, A. S., WEINREIB, R., STAAB, J. P., ZAJECKA, J. M., BRUNO, C. J., HENDERSON, M. A., REINUS, J. F., et al. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03316.x · Cited by 142 · cited 1×
“…in patients with malignant melanoma and hepatitis C have demonstrated that pretreatment with paroxetine can signifi cantly reduce the development of depressive symptoms, especially in those individuals with elevated symptoms of depression at baseline (Musselman et al., 2001a; Raison et al., 2007).”
BackgroundTeeling, J. L., Cunningham, C., Newman, T. A., & Perry, V. H. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.11.006 · Cited by 139
Depression as a Risk Factor for Cancer: From Pathophysiological Advances to Treatment Implications
Currier, M. B., & Nemeroff, C. B. (2014) · Annual Review of Medicine · doi:10.1146/annurev-med-061212-171507 · Cited by 126 · cited 1×
“For example, increased infl ammatory markers have been identifi ed in patients with depression (Currier & Nemeroff, 2014; Miller et al., 2008; Musselman et al., 2001b).”
BackgroundSelf-citationCircadian disruption in experimental cancer processes
Filipski, E., & Lévi, F. (2009) · Integrative Cancer Therapies · doi:10.1177/1534735409352085 · Cited by 125 · cited 1×
“…in the initiation of ovarian cancer (Rae & Hillier, 2005), the failure of cancer cells to undergo apoptosis (Melhem et al., 2009; Pan et al., 2011; Schlossmacher et al., 2011), the development of chemotherapy resistance (Pang et al., 2006), and accelerated tumour growth (Filipski & Levi, 2009).”
BackgroundProstaglandins mediate depressive-like behaviour induced by endotoxin in mice
de Paiva, V. N., Lima, S. N. P., Fernandes, M. M., Soncini, R., Andrade, C. A. F., & Giusti-Paiva, A. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.07.015 · Cited by 104 · cited 1×
“Inhibition of cyclooxygenase (COX)-1 and COX-2 has been shown to inhibit depressive-like behaviours in animal models following the administration of an infl ammatory stimulus (de Paiva et al., 2010; Teeling et al., 2010).”
BackgroundVagal regulation, cortisol, and sleep disruption in women with metastatic breast cancer
Palesh, O., Zeitzer, J. M., Conrad, A., Giese-Davis, J., Mustian, K. M., Popek, V., Nga, K., & Spiegel, D. (2008) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27280 · Cited by 87
Mehta, D., Raison, C. L., Woolwine, B. J., Haroon, E., Binder, E. B., Miller, A. H., & Felger, J. C. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.04.004 · Cited by 74 · cited 1×
“In this patient population of treatmentresistant depression, a number of genetic transcripts associated with gluconeogenesis and cholesterol transport were identifi ed that predicted antidepressant response to this agent (Mehta et al., 2013).”
BackgroundFITZGERALD, P., O'BRIEN, S. M., SCULLY, P., RIJKERS, K., SCOTT, L. V., & DINAN, T. G. (2006) · Psychological Medicine · doi:10.1017/s003329170500632x · Cited by 66 · cited 1×
“Moreover, depressed patients who do not respond to antidepressant treatment continue to exhibit increased infl ammatory markers (Fitzgerald et al., 2006; Lanquillon et al., 2000; Sluzewska et al., 1997).”
Background
Cited by
Liu, Q., He, H., Yang, J., Feng, X., Zhao, F., & Lyu, J. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.08.002 · Cited by 1,452
Depression in cancer: The many biobehavioral pathways driving tumor progression
Bortolato, B., Hyphantis, T. N., Valpione, S., Perini, G., Maes, M., Morris, G., Kubera, M., Köhler, C. A., Fernandes, B. S., Stubbs, B., et al. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.11.004 · Cited by 375
Endometriosis and cancer: a systematic review and meta-analysis
Kvaskoff, M., Mahamat-Saleh, Y., Farland, L. V., Shigesi, N., Terry, K. L., Harris, H. R., Roman, H., Becker, C. M., As-Sanie, S., Zondervan, K. T., et al. (2021) · Human Reproduction Update · doi:10.1093/humupd/dmaa045 · Cited by 303
Burden of depression in China, 1990–2017: Findings from the global burden of disease study 2017
Ren, X., Yu, S., Dong, W., Yin, P., Xu, X., & Zhou, M. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.011 · Cited by 234
Steffen, A., Nübel, J., Jacobi, F., Bätzing, J., & Holstiege, J. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02546-8 · Cited by 212
Metadata
- Authors
- Sotelo, J. L., Musselman, D., & Nemeroff, C.
- Venue
- International Review of Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2014-02
- Volume
- 26
- Issue
- 1
- Pages
- 16-30
- ISSN
- 0954-0261 (ISSN-L)
- 1369-1627
- OpenAlex
- W2099725757
- Cited by
- 179
- References
- 65
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.